Metronomic chemotherapy for cancer treatment: a decade of clinical studiesROMITI, Adriana; COX, M. Christina; SARCINA, Ida et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 1, pp 13-33, issn 0344-5704, 21 p.Article

The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondinDAMBER, Jan-Erik; VALLBO, Christina; ALBERTSSON, Per et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 354-360, issn 0344-5704, 7 p.Article

Low-dose metronomic chemotherapy: A systematic literature analysisLIEN, K; GEORGSDOTTIR, S; SIVANATHAN, L et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3387-3395, issn 0959-8049, 9 p.Article

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?PENEL, Nicolas; ADENIS, Antoine; BOCCI, Guido et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 1, pp 40-50, issn 1040-8428, 11 p.Article

The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With CyclophosphamideROZADOS, Viviana R; MAINETTI, Leandro E; RICO, María J et al.Oncology research. 2010, Vol 18, Num 11-12, pp 601-605, issn 0965-0407, 5 p.Article

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer modelHONGJU WU; YAN XIN; JING ZHAO et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 879-887, issn 0344-5704, 9 p.Article

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testingSHAN MAN; MUNOZ, Raquel; KERBEL, Robert S et al.Cancer metastasis reviews. 2007, Vol 26, Num 3-4, pp 737-747, issn 0167-7659, 11 p.Article

Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the do ut des paradigm)DE CASTRO JUNIOR, Gilberto; PUGLISI, Fabio; DE AZAMBUJA, Evandro et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 1, pp 40-50, issn 1040-8428, 11 p.Article

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimensFAIVRE, C; BARBOLOSI, D; PASQUIER, E et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 4, pp 1013-1019, issn 0344-5704, 7 p.Article

Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter ExperienceZAPLETALOVA, D; ANDRE, N; SKOTAKOVA, J et al.Oncology. 2012, Vol 82, Num 5, pp 249-260, issn 0030-2414, 12 p.Article

Chimiothérapie métronomique en 2011: actualités et perspectives = Metronomic chemotherapy in 2011: update and perspectivesBENBRAHIM, Zineb; MASSARD, Christophe; EL MESBAHI, Omar et al.Bulletin du cancer. 2011, Vol 98, Num 12, pp 1447-1454, issn 0007-4551, 8 p.Article

Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New PackageBAHL, Ankur; BAKHSHI, Sameer.Indian journal of pediatrics. 2012, Vol 79, Num 12, pp 1617-1622, issn 0019-5456, 6 p.Article

Influence of formulation vehicle on metronomic taxane chemotherapy : Albumin-bound versus cremophor EL - based paclitaxelNG, Sylvia S. W; SPARREBOOM, Alex; SHAKED, Yuval et al.Clinical cancer research. 2006, Vol 12, Num 14, pp 4331-4338, issn 1078-0432, 8 p., 1Article

Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosisSEONG TAE PARK; JEONG WON JANG; JONG YOUNG CHOI et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 6, pp 1029-1037, issn 0344-5704, 9 p.Article

Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapyTUETTENBERG, Jochen; GROBHOLZ, Rainer; SEIZ, Marcel et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 9, pp 1239-1244, issn 0171-5216, 6 p.Article

Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancerTAS, Faruk; DURANYILDIZ, Derya; SOYDINC, Hilal O et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 5, pp 721-725, issn 0344-5704, 5 p.Article

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancerFEDELE, P; MARINO, A; CINIERI, S et al.European journal of cancer (1990). 2012, Vol 48, Num 1, pp 24-29, issn 0959-8049, 6 p.Article

Oral Metronomic Cyclophosphamide with and without Methotrexate as Palliative Treatment for Patients with Metastatic Breast CarcinomaGEBBIA, Vittorio; BOUSSEN, Hamouda; ROSARIA VALERIO, Maria et al.Anticancer research. 2012, Vol 32, Num 2, pp 529-536, issn 0250-7005, 8 p.Article

Antiangiogenic strategies in breast cancer managementGIOVANNINI, Monica; ALDRIGHETTI, Daniela; ZUCCHINELLI, Patrizia et al.Critical reviews in oncology/hematology. 2010, Vol 76, Num 1, pp 13-35, issn 1040-8428, 23 p.Article

Endogenous angiogenesis inhibitorsFOLKMAN, Judah.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2004, Vol 112, Num 7-8, pp 496-507, issn 0903-4641, 12 p.Article

Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy RegimensCRUZ-MUNOZ, William; SHAN MAN; KERBEL, Robert S et al.Clinical cancer research (Print). 2009, Vol 15, Num 15, pp 4867-4874, issn 1078-0432, 8 p.Article

Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cellsVIVES, Marta; GINESTA, Mireia M; GRACOVA, Kristina et al.International journal of cancer (Print). 2013, Vol 133, Num 10, pp 2464-2472, issn 0020-7136, 9 p.Article

Sorafenib enhances the in vitro anti-endothelial effects of low dose (metronomic) chemotherapyMURRAY, Alexandra; LITTLE, Samantha J; STANLEY, Paul et al.Oncology reports. 2010, Vol 24, Num 4, pp 1049-1058, issn 1021-335X, 10 p.Article

Metronomic chemotherapy in advanced soft tissue sarcomasITALIANO, Antoine; TOULMONDE, Maud; LORTAL, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 1, pp 197-202, issn 0344-5704, 6 p.Article

Metronomic paclitaxel-loaded mPEG-PLA nanoparticles show enhanced anti-tumor efficacy compared to maximum tolerated dose administrationTAN FEI; YANG, Lian-Juan; MO, Xiao-Hui et al.Journal of nanoparticle research. 2014, Vol 16, Num 11, issn 1388-0764, 2706.1-2706.16Article